Bronchiectasis Is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis

作者: Anne‐Marie Quirke , Elizabeth Perry , Alison Cartwright , Clive Kelly , Anthony De Soyza

DOI: 10.1002/ART.39226

关键词:

摘要: Objective To examine the potential of chronic severe bacterial infection to generate rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs), by studying patients with bronchiectasis (BR) alone BR arthritis (BR/RA). Methods We studied 122 alone, 50 BR/RA, RA without lung disease, as well 87 asthma 79 healthy subjects controls. RF levels were measured using an automated analyzer, cyclic citrullinated peptide 2 (CCP-2) was used detect ACPAs. The fine specificities α-enolase 1 (CEP-1), Cit-vimentin, Cit-fibrinogen their arginine-containing control peptides (arginine-containing [REP-1], vimentin, fibrinogen) enzyme-linked immunosorbent assay. Results Among subjects, 39% 42%, respectively, ever-smokers. frequency positivity in serum increased compared controls (25% versus 10%), frequencies CCP-2 (5% 0%), CEP-1 (7% 4%), Cit-vimentin (12% although only differences for significant (P Conclusion Bronchiectasis is unusual but potent model induction autoimmunity lung. Our study suggests that ACPA response not citrulline specific during early stages tolerance breakdown becomes more whom BR/RA develops.

参考文章(25)
Lars Klareskog, Anca I. Catrina, Autoimmunity: Lungs and citrullination Nature Reviews Rheumatology. ,vol. 11, pp. 261- 262 ,(2015) , 10.1038/NRRHEUM.2015.38
Francesca Ingegnoli, Roberto Castelli, Roberta Gualtierotti, Rheumatoid factors: Clinical applications Disease Markers. ,vol. 35, pp. 727- 734 ,(2013) , 10.1155/2013/726598
Elizabeth Perry, Chris Stenton, Clive Kelly, Paul Eggleton, David Hutchinson, Anthony De Soyza, RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients. European Respiratory Journal. ,vol. 44, pp. 1082- 1085 ,(2014) , 10.1183/09031936.00064014
Karin Lundberg, Andrew Kinloch, Benjamin A. Fisher, Natalia Wegner, Robin Wait, Peter Charles, Ted R. Mikuls, Patrick J. Venables, Antibodies to citrullinated α‐enolase peptide 1 are specific for rheumatoid arthritis and cross‐react with bacterial enolase Arthritis & Rheumatism. ,vol. 58, pp. 3009- 3019 ,(2008) , 10.1002/ART.23936
Lars Klareskog, Vivianne Malmström, Karin Lundberg, Leonid Padyukov, Lars Alfredsson, Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Seminars in Immunology. ,vol. 23, pp. 92- 98 ,(2011) , 10.1016/J.SMIM.2011.01.014
P. Suwannalai, L. A. van de Stadt, H. Radner, G. Steiner, H. S. El-Gabalawy, C. M. Jol-van der Zijde, M. J. van Tol, D. van Schaardenburg, T. W. J. Huizinga, R. E. M. Toes, L. A. Trouw, Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 64, pp. 1323- 1328 ,(2012) , 10.1002/ART.33489
Elliot D. Rosenstein, Robert A. Greenwald, Laura J. Kushner, Gerald Weissmann, Hypothesis: The Humoral Immune Response to Oral Bacteria Provides a Stimulus for the Development of Rheumatoid Arthritis Inflammation. ,vol. 28, pp. 311- 318 ,(2004) , 10.1007/S10753-004-6641-Z
V. Michael Holers, Kevin D. Deane, M. Kristen Demoruelle, Michael H. Weisman, Philip L. Simonian, David A. Lynch, Peter B. Sachs, Isabel F. Pedraza, Annie R. Harrington, Jason R. Kolfenbach, Christopher C. Striebich, Quyen N. Pham, Colin D. Strickland, Brian D. Petersen, Mark C. Parish, Lezlie A. Derber, Jill M. Norris, Brief Report: Airways abnormalities and rheumatoid arthritis–related autoantibodies in subjects without arthritis: Early injury or initiating site of autoimmunity? Arthritis & Rheumatism. ,vol. 64, pp. 1756- 1761 ,(2012) , 10.1002/ART.34344
Solbritt Rantapää-Dahlqvist, Ben A. W. de Jong, Ewa Berglin, Göran Hallmans, Göran Wadell, Hans Stenlund, Ulf Sundin, Walther J. van Venrooij, Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 48, pp. 2741- 2749 ,(2003) , 10.1002/ART.11223